[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # Vaxcyte, Inc. Common Stock (PCVX) Vaxcyte doses first participants in Phase X trial for VAX-31, a vaccine for invasive pneumococcal disease. This news, coupled with positive data and sector rotation, is driving increased social dominance and creator activity. ### About Vaxcyte, Inc. Common Stock Vaxcyte, Inc. Common Stock (PCVX) is a publicly traded stock in the healthcare sector focused on vaccine development. Vaxcyte, Inc. Common Stock uses the ticker $PCVX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Vaxcyte, Inc. Common Stock (PCVX) trading volume is up XXXXX% from the previous X months. - Vaxcyte, Inc. Common Stock (PCVX) social dominance is up XXXXXX% from the previous month. - Vaxcyte, Inc. Common Stock (PCVX) Galaxy Scoreโข is up XXXXX% from the previous week. ### Price: $XXXXX  [Price 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/close.tsv) The stock price has seen recent increases attributed to positive vaccine data, a manufacturing agreement, and sector rotation into biotech, amplified by increased social dominance and creator activity. 24-Hour: -XXXX% 7-Day: XXXX% 30-Day: -XXXX% 1-Year High: $XXXXX on 2025-01-28 1-Year Low: $XX on 2025-04-10 ### AltRank: XXXXX  [AltRank 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/alt_rank.tsv) Vaxcyte, Inc. Common Stock (PCVX) is currently AltRank #1,552 based on combined combined social and market metrics Daily Average: XXXXX X Week: XXXXX +402 X Month: XXXXX -XXX X Months: XXXXX -XXX X Year: XXXXX +502 1-Year High: XXXXX on 2025-08-06 1-Year Low: XX on 2025-04-01 ### Galaxy Score: XXXXX  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/galaxy_score.tsv) Current Value: XXXXX Daily Average: XX X Week: XX +6 X Month: XX -XX X Months: XX -XX X Year: XX -XX 1-Year High: XX on 2025-05-15 1-Year Low: XX on 2025-11-17 ### Engagements: XXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/interactions.tsv) Current Value: XXX Daily Average: XXXXX X Week: XXXXX -XX% X Month: XXXXXX +166% X Months: XXXXXXX -XX% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXXX on 2025-03-31 1-Year Low: XX on 2025-11-03 Engagements by network (24h): X: XXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XXX +2.40% X Month: XXX +87% X Months: XXXXX +30% X Year: XXXXX +56% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-09-19 Mentions by network (24h): X: XX ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Vaxcyte, Inc. Common Stock (PCVX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX X Week: XXX +1.50% X Month: XXX +82% X Months: XXXXX +110% X Year: XXXXX +111% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-10-26 The most influential creators that mention Vaxcyte, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XX | | [@seedytx19](/creator/twitter/seedytx19) | X | XXXXX | X | XX | | [@linhnguyen64143](/creator/twitter/linhnguyen64143) | X | XX | X | XX | [View More](/list/creators/$pcvx/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% +5% X Month: XX% -XX% X Months: XX% -XX% X Year: XX% -XX% 1-Year High: XXX% on 2025-04-19 1-Year Low: XX% on 2025-09-11 Most Supportive Themes: - Stock Alerts and Mentions: (40%) Posts mentioning $PCVX in conjunction with other stocks, often in the context of alerts or watchlists. - Biotech Catalyst and News: (30%) Posts discussing $PCVX within the context of biotech catalysts, clinical trials, and industry news. Most Critical Themes: - General Market Downturn: (10%) Mentions of $PCVX within the context of a downturn in the healthcare sector. - Negative Sentiment: (5%) Posts expressing negative sentiment towards $PCVX or the vaccine industry. ### Social Dominance: XXXXXXX%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/social_dominance.tsv) Current Value: XXXXXXX% Daily Average: XXXXXX% X Week: XXXXXXX% +0.00249% X Month: XXXXX% +0.01% X Months: XXXXX% +0.0052% X Year: XXXXX% -XXXXXXXXXXXXXXXXXXXXXX% 1-Year High: XXXXX% on 2025-01-02 1-Year Low: XXXXX% on 2025-09-19 ### Market Dominance: XXXXXXX%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/market_dominance.tsv) Current Value: XXXXXXX% Daily Average: X% 1-Year High: XXXXX% on 2025-03-31 1-Year Low: XXXXXXX% on 2025-09-17 ### Market Cap: $XXXXXXXXXXXXX  [Market Cap 24-Hour Time-Series Raw Data](/topic/$pcvx/time-series/market_cap.tsv) Current Value: $XXXXXXXXXXXXX Daily Average: $XXXXXXXXXXXXX X Week: $XXXXXXXXXXXXX +$0.09% X Month: $XXXXXXXXXXXXX +$7.40% X Months: $XXXXXXXXXXXXX +$32% X Year: $XXXXXXXXXXXXX -$49% 1-Year High: $XXXXXXXXXXXXXX on 2025-01-28 1-Year Low: $XXXXXXXXXXXXX on 2025-04-10 ### Top Vaxcyte, Inc. Common Stock Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$PCVX +1.36% today as Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048712560386157) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-08T15:15Z 3011 followers, XXX engagements "Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults $PCVX" [X Link](https://x.com/lifesciencerpt/status/1998000631919882242) [@lifesciencerpt](/creator/x/lifesciencerpt) 2025-12-08T12:04Z 6452 followers, XXX engagements "$PCVX ๐โ Guys Don't miss the next move in a few hours. ๐ธโก" [X Link](https://x.com/Erin72517/status/1997671515467256302) [@Erin72517](/creator/x/Erin72517) 2025-12-07T14:16Z X followers, XX engagements "$PCVX Guys Don't miss the Target price for Next Week. ๐ธ๐" [X Link](https://x.com/yvrob47800/status/1997591694586544196) [@yvrob47800](/creator/x/yvrob47800) 2025-12-07T08:59Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Vaxcyte doses first participants in Phase X trial for VAX-31, a vaccine for invasive pneumococcal disease. This news, coupled with positive data and sector rotation, is driving increased social dominance and creator activity.
Vaxcyte, Inc. Common Stock (PCVX) is a publicly traded stock in the healthcare sector focused on vaccine development.
Vaxcyte, Inc. Common Stock uses the ticker $PCVX for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price has seen recent increases attributed to positive vaccine data, a manufacturing agreement, and sector rotation into biotech, amplified by increased social dominance and creator activity.
24-Hour: -XXXX% 7-Day: XXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2025-01-28
1-Year Low: $XX on 2025-04-10
AltRank 24-Hour Time-Series Raw Data
Vaxcyte, Inc. Common Stock (PCVX) is currently AltRank #1,552 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +402
X Month: XXXXX -XXX
X Months: XXXXX -XXX
X Year: XXXXX +502
1-Year High: XXXXX on 2025-08-06
1-Year Low: XX on 2025-04-01
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +6
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-05-15
1-Year Low: XX on 2025-11-17
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX +166%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-03-31
1-Year Low: XX on 2025-11-03
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +2.40%
X Month: XXX +87%
X Months: XXXXX +30%
X Year: XXXXX +56%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-19
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Vaxcyte, Inc. Common Stock (PCVX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX +1.50%
X Month: XXX +82%
X Months: XXXXX +110%
X Year: XXXXX +111%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-26
The most influential creators that mention Vaxcyte, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
| @linhnguyen64143 | X | XX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +5%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-04-19
1-Year Low: XX% on 2025-09-11
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXX%
X Week: XXXXXXX% +0.00249%
X Month: XXXXX% +0.01%
X Months: XXXXX% +0.0052%
X Year: XXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXX% on 2025-09-19
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-09-17
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$0.09%
X Month: $XXXXXXXXXXXXX +$7.40%
X Months: $XXXXXXXXXXXXX +$32%
X Year: $XXXXXXXXXXXXX -$49%
1-Year High: $XXXXXXXXXXXXXX on 2025-01-28
1-Year Low: $XXXXXXXXXXXXX on 2025-04-10
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$PCVX +1.36% today as Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults More Info:"
X Link @OzmosiHealth 2025-12-08T15:15Z 3011 followers, XXX engagements
"Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults $PCVX"
X Link @lifesciencerpt 2025-12-08T12:04Z 6452 followers, XXX engagements
"$PCVX ๐โ Guys Don't miss the next move in a few hours. ๐ธโก"
X Link @Erin72517 2025-12-07T14:16Z X followers, XX engagements
"$PCVX Guys Don't miss the Target price for Next Week. ๐ธ๐"
X Link @yvrob47800 2025-12-07T08:59Z XX followers, XX engagements
/topic/$pcvx